Literature DB >> 33164230

Insights into disparities observed with COVID-19.

J M Carethers1.   

Abstract

The onset of human disease by infection with SARS-CoV-2 causing COVID-19 has revealed risk factors for disease severity. There are four identified factors that put one at high risk for infection and/or mortality creating a disparity: age, co-morbidities, race/ethnicity and gender. Data indicate that the older a person is, and/or the presence of obesity and diabetes, cardiovascular disease and chronic kidney disease place one at higher risk for COVID-19. In the United States, specific race/ethnicities, particularly African Americans and Native Americans, are strong COVID-19 risk components. Male gender has also emerged as a severity risk factor. For age and racial/ethnicities, the accumulation of health co-morbidities is common precipitating mechanisms. In particular, underlying socio-economic structures in the United States likely drive development of co-morbidities, putting affected populations at higher risk for severe COVID-19. Sudden cardiac death triggered by a common sodium channel variant in African Americans with COVID-19 has not been evaluated as a cause for racial disparity. There is no evidence that racial/ethnic differences for COVID-19 are caused by ABO blood groups, use of angiotensin-converting enzyme (ACE) inhibitors or from amino acid substitutions in the SARS-CoV-2 spike protein. There is growing evidence that androgen-enabled expression of ACE2 receptors and the serine protease TMPRSS2, two permissive elements engaging the SARS-CoV-2 spike protein for infection, may contribute to severe COVID-19 in men. Overall, COVID-19 has generated disparities for who is infected and the severity of that infection. Understanding the mechanisms for the disparity will help nullify the differences in risk for COVID-19.
© 2020 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  ACE2; African American; COVID-19; Hispanic/Latinx; SARS-CoV-2; TMPRSS2; age; androgen; chronic kidney disease; co-morbidity; diabetes; disparity; ethnicity; hypertension; race

Mesh:

Year:  2020        PMID: 33164230      PMCID: PMC9325576          DOI: 10.1111/joim.13199

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   13.068


  60 in total

1.  Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters.

Authors:  Jack W London; Elnara Fazio-Eynullayeva; Matvey B Palchuk; Peter Sankey; Christopher McNair
Journal:  JCO Clin Cancer Inform       Date:  2020-07

2.  Sex hormones signal why virus hits men harder.

Authors:  Meredith Wadman
Journal:  Science       Date:  2020-06-05       Impact factor: 47.728

3.  TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.

Authors:  Hannah Limburg; Anne Harbig; Dorothea Bestle; David A Stein; Hong M Moulton; Julia Jaeger; Harshavardhan Janga; Kornelia Hardes; Janine Koepke; Leon Schulte; Andreas Rembert Koczulla; Bernd Schmeck; Hans-Dieter Klenk; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.

Authors:  Charles L Bennett; Douglas K Price; Simon Kim; Dachao Liu; Borko D Jovanovic; Derek Nathan; Margaret E Johnson; Jeffrey S Montgomery; Kelly Cude; Justin C Brockbank; Oliver Sartor; William D Figg
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

5.  A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring.

Authors:  Ayelet Alpert; Yishai Pickman; Michael Leipold; Yael Rosenberg-Hasson; Xuhuai Ji; Renaud Gaujoux; Hadas Rabani; Elina Starosvetsky; Ksenya Kveler; Steven Schaffert; David Furman; Oren Caspi; Uri Rosenschein; Purvesh Khatri; Cornelia L Dekker; Holden T Maecker; Mark M Davis; Shai S Shen-Orr
Journal:  Nat Med       Date:  2019-03-06       Impact factor: 53.440

6.  SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.

Authors:  Waradon Sungnak; Ni Huang; Christophe Bécavin; Marijn Berg; Rachel Queen; Monika Litvinukova; Carlos Talavera-López; Henrike Maatz; Daniel Reichart; Fotios Sampaziotis; Kaylee B Worlock; Masahiro Yoshida; Josephine L Barnes
Journal:  Nat Med       Date:  2020-04-23       Impact factor: 53.440

Review 7.  Impact of sex and gender on COVID-19 outcomes in Europe.

Authors:  Catherine Gebhard; Vera Regitz-Zagrosek; Hannelore K Neuhauser; Rosemary Morgan; Sabra L Klein
Journal:  Biol Sex Differ       Date:  2020-05-25       Impact factor: 5.027

Review 8.  Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans.

Authors:  John R Giudicessi; Dan M Roden; Arthur A M Wilde; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2020-05-05       Impact factor: 6.343

9.  Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.

Authors:  Muthiah Vaduganathan; Orly Vardeny; Thomas Michel; John J V McMurray; Marc A Pfeffer; Scott D Solomon
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

10.  Racial, Economic, and Health Inequality and COVID-19 Infection in the United States.

Authors:  Vida Abedi; Oluwaseyi Olulana; Venkatesh Avula; Durgesh Chaudhary; Ayesha Khan; Shima Shahjouei; Jiang Li; Ramin Zand
Journal:  J Racial Ethn Health Disparities       Date:  2020-09-01
View more
  25 in total

1.  Determining whether ethnic minorities with severe obesity face a disproportionate risk of serious disease and death from COVID-19: outcomes from a Southern California-based retrospective cohort study.

Authors:  Hemesh Mahesh Patel; Shefali Khandwala; Poonam Somani; Qiaowu Li; Stephanie Tovar; Alejandra Montano
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

Review 2.  RAGE against the Machine: Can Increasing Our Understanding of RAGE Help Us to Battle SARS-CoV-2 Infection in Pregnancy?

Authors:  Courtney K Kurashima; Po'okela K Ng; Claire E Kendal-Wright
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

3.  Monkeypox has devastated the world; should we prepare for the outbreak of a new pandemic?

Authors:  Malik Ali Ehtsham Awan; Maria Waseem; Areesh Fatima Sahito; Abdul Moiz Sahito; Govinda Khatri; Masood Ahmed Butt; Sarker Ramproshad; Banani Mondal; Mohammad Mehedi Hasan
Journal:  Ann Med Surg (Lond)       Date:  2022-06-23

4.  Associations between perceived discrimination and immune cell composition in the Jackson Heart Study.

Authors:  Jacob E Aronoff; Edward B Quinn; Allana T Forde; Láshauntá M Glover; Alexander Reiner; Thomas W McDade; Mario Sims
Journal:  Brain Behav Immun       Date:  2022-04-02       Impact factor: 19.227

5.  Percutaneous and Open Tracheostomy in Patients With COVID-19: The Weill Cornell Experience in New York City.

Authors:  Sallie M Long; Noah Z Feit; Alexander Chern; Victoria Cooley; Shanna S Hill; Kapil Rajwani; Edward J Schenck; Brendon Stiles; Andrew B Tassler
Journal:  Laryngoscope       Date:  2021-06-09       Impact factor: 2.970

6.  The Impact of COVID-19 on the Latinx Population: A Scoping Literature Review.

Authors:  Karen S Moore
Journal:  Public Health Nurs       Date:  2021-04-20       Impact factor: 1.770

7.  Racial and ethnic disparities in colorectal cancer incidence and mortality.

Authors:  John M Carethers
Journal:  Adv Cancer Res       Date:  2021-05-05       Impact factor: 5.767

8.  On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.

Authors:  László Földvári-Nagy; Tamás Schnabel; Gabriella Dörnyei; Tamás Korcsmáros; Katalin Lenti
Journal:  Cell Commun Signal       Date:  2021-01-13       Impact factor: 5.712

Review 9.  Environmental Determinants of Coronavirus Disease 2019 (COVID-19).

Authors:  Eric B Brandt; Tesfaye B Mersha
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-05       Impact factor: 4.806

10.  Sickness and the Social Brain: Love in the Time of COVID.

Authors:  Caroline J Smith; Staci D Bilbo
Journal:  Front Psychiatry       Date:  2021-02-22       Impact factor: 5.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.